Prime Medicine (PRME) Current Assets (2021 - 2026)

Prime Medicine (PRME) has 6 years of Current Assets data on file, last reported at $137.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 15.8% year-over-year to $137.9 million; the trailing twelve-month figure through Mar 2026 stood at $137.9 million (down 15.8% YoY), and the FY2025 full-year result was $181.3 million, down 14.44% from the prior year.
• Current Assets for Q1 2026 stood at $137.9 million, down from $181.3 million in the prior quarter.
• Across five years, Current Assets topped out at $296.6 million in Q4 2022 and bottomed at $121.3 million in Q2 2025.
• The 5-year median for Current Assets is $184.5 million (2023), against an average of $195.1 million.
• The widest annual swing landed in 2023, when Current Assets plunged 51.8%; it then soared 48.2% in 2024.
• A 5-year view of Current Assets shows it stood at $296.6 million in 2022, then slumped by 51.8% to $143.0 million in 2023, then jumped by 48.2% to $211.9 million in 2024, then decreased by 14.44% to $181.3 million in 2025, then decreased by 23.94% to $137.9 million in 2026.
• The last three Current Assets figures came in at $137.9 million (Q1 2026), $181.3 million (Q4 2025), and $231.4 million (Q3 2025), per Business Quant data.

Peer Comparison